Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 55 (RN7SKP55) is classified as a pseudogene related to the *RN7SK* gene, which encodes the 7SK small nuclear RNA—an abundant noncoding RNA that regulates RNA polymerase II transcription elongation through interaction with positive transcription elongation factor b (P-TEFb)[4][1][2]. RN7SKP55 itself does not encode a functional product and is not considered a therapeutic target, enzyme, receptor, or any other druggable protein class. The precise biological role (if any) of RN7SKP55 is not established, and there are no known disease associations, interacting drugs, biomarkers, or relevant therapeutic safety concerns[4]. As a pseudogene, it is primarily of interest for genomic annotation and does not perform the regulatory or scaffold functions attributed to the canonical RN7SK RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 55 (RN7SKP55).